Efficacy and Safety of Efpeglenatide Versus Placebo in Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Basal Insulin Alone or in Combination With Oral Antidiabetic Drug(s)
Clinical trial NCT03713684 · TERMINATED
Trial details
- NCT number
- NCT03713684
- Sponsor
- Sanofi
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2018-11-09
- Primary completion
- 2020-11-20
- Enrollment
- 370
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.